Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy

Epilepsia

Volumn 55, Issue 4, 2014, Pages 601-608

  Hatch, Robert J ^a   Reid, Christopher A ^a   Petrou, Steven ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antiepileptic drugs; Epilepsy; In vitro; Mouse model; Seizures

Indexed keywords

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM CHANNEL T TYPE; CARBAMAZEPINE; RETIGABINE; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT; ANTICONVULSIVE AGENT; CARBAMIC ACID DERIVATIVE; PHENYLENEDIAMINE DERIVATIVE; SCN1B PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPILEPSY; EXPERIMENTAL SEIZURE; GENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; SEIZURE; SPIKE; TEMPERATURE; ACTION POTENTIAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CA1 REGION, HIPPOCAMPAL; CARBAMATES; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; EPILEPSY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE NET; ORGAN CULTURE TECHNIQUES; PHENYLENEDIAMINES; UP-REGULATION; VOLTAGE-GATED SODIUM CHANNEL BETA-1 SUBUNIT;

EID: 84899480171     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12568     Document Type: Article

References (39)

1. Steinlein OK,. Channelopathies can cause epilepsy in man. Eur J Pain 2002; 6 (Suppl. A): 27-34.
2. Ogiwara I, Miyamoto H, Morita N, et al. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007; 27: 5903-5914.
3. Tan HO, Reid CA, Single FN, et al. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc Natl Acad Sci USA 2007; 104: 17536-17541.
4. Wimmer VC, Reid CA, Mitchell S, et al. Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus. J Clin Invest 2010; 120: 2661-2671.
5. Yu FH, Mantegazza M, Westenbroek RE, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006; 9: 1142-1149.
6. Kearney JA, Plummer NW, Smith MR, et al. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001; 102: 307-317.
7. Liautard C, Scalmani P, Carriero G, et al. Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome. Epilepsia 2013; 54: 1251-1261.
8. Kwan P, Brodie M,. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
9. +-channel beta1 subunit gene SCN1B. Nat Genet 1998; 19: 366-370.
10. Richards KL, Kurniawan ND, Yang Z, et al. Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy. Neurology 2013; 80: 1240-1246.
11. Schuchmann S, Schmitz D, Rivera C, et al. Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat Med 2006; 12: 817-823.
12. McLeod F, Ganley R, Williams L, et al. Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome. Neuroscience 2013; 231: 195-205.
13. Kile KB, Tian N, Durand DM,. Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro. Epilepsia 2008; 49: 488-499.
14. Bracci E, Vreugdenhil M, Hack SP, et al. On the synchronizing mechanisms of tetanically induced hippocampal oscillations. J Neurosci 1999; 19: 8104-8113.
15. Traub RD, Jefferys JG, Whittington MA,. Simulation of gamma rhythms in networks of interneurons and pyramidal cells. J Comput Neurosci 1997; 4: 141-150.
16. Whittington MA, Stanford IM, Colling SB, et al. Spatiotemporal patterns of gamma frequency oscillations tetanically induced in the rat hippocampal slice. J Physiol 1997; 502 (Pt 3): 591-607.
17. Whittington MA, Traub RD, Jefferys JG,. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995; 373: 612-615.
18. Alarcon G, Binnie CD, Elwes RD, et al. Power spectrum and intracranial EEG patterns at seizure onset in partial epilepsy. Electroencephalogr Clin Neurophysiol 1995; 94: 326-337.
19. Fisher RS, Van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-472.
20. Colling SB, Stanford IM, Traub RD, et al. Limbic gamma rhythms. I. Phase-locked oscillations in hippocampal CA1 and subiculum. J Neurophysiol 1998; 80: 155-161.
21. Eng DL, Kocsis JD,. Activity-dependent changes in extracellular potassium and excitability in turtle olfactory nerve. J Neurophysiol 1987; 57: 740-754.
22. Kocsis JD, Eng DL, Gordon TR, et al. Functional differences between 4-aminopyridine and tetraethylammonium-sensitive potassium channels in myelinated axons. Neurosci Lett 1987; 75: 193-198.
23. Avoli M, Panuccio G, Herrington R, et al. Two different interictal spike patterns anticipate ictal activity in vitro. Neurobiol Dis 2013; 52: 168-176.
24. Boido D, Jesuthasan N, de Curtis M, et al. Network dynamics during the progression of seizure-like events in the hippocampal-parahippocampal regions. Cereb Cortex 2014; 24: 163-173.
25. 2+ induced epileptiform activity in rat hippocampal and entorhinal cortex slices during adolescence. Brain Res Dev Brain Res 1995; 87: 145-152.
26. Kole MHP, Ilschner SU, Kampa BM, et al. Action potential generation requires a high sodium channel density in the axon initial segment. Nat Neurosci 2008; 11: 178-186.
27. Lorincz A, Nusser Z,. Cell-type-dependent molecular composition of the axon initial segment. J Neurosci 2008; 28: 14329-14340.
28. Wimmer VC, Reid CA, So EY-W, et al. Axon initial segment dysfunction in epilepsy. J Physiol 2010; 588: 1829-1840.
29. 2+ channels influence action potential generation and timing. Neuron 2009; 61: 259-271.
30. Schwarz JRJ, Grigat GG,. Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers. Epilepsia 1988; 30: 286-294.
31. Uebachs M, Albus C, Opitz T, et al. Loss of β(1) accessory Na(+) channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na(+) currents. Epilepsia 2012; 53: 1959-1967.
32. Main MJ, Cryan JE, Dupere JR, et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 2000; 58: 253-262.
33. Wickenden AD, Yu W, Zou A, et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 2000; 58: 591-600.
34. + channels. J Neurosci 2012; 32: 5716-5727.
35. + channels by the sodium channel β1 subunit. Proc Natl Acad Sci USA 2012; 109: 18577-18582.
36. Armand V, Rundfeldt C, Heinemann U,. Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices. Epilepsia 2000; 41: 28-33.
37. ++ model in the hippocampal slice preparation. Epilepsy Res 2000; 38: 53-66.
38. Ciliberto MA, Weisenberg JL, Wong M,. Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy. Drug Healthc Patient Saf 2012; 4: 81-86.
39. Crepeau AZ, Moseley BD, Wirrell EC,. Specific safety and tolerability considerations in the use of anticonvulsant medications in children. Drug Healthc Patient Saf 2012; 4: 39-54.